CN213374413U - Multifunctional integrated test injection device - Google Patents
Multifunctional integrated test injection device Download PDFInfo
- Publication number
- CN213374413U CN213374413U CN202020840275.7U CN202020840275U CN213374413U CN 213374413 U CN213374413 U CN 213374413U CN 202020840275 U CN202020840275 U CN 202020840275U CN 213374413 U CN213374413 U CN 213374413U
- Authority
- CN
- China
- Prior art keywords
- test
- tube
- injection
- needle
- testing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model discloses a multi-functional integral type test injection apparatus, including swing joint spare, injection subassembly and test component, through swing joint spare is as an organic whole with injection subassembly and test component swing joint, the centre of injection subassembly and test component is located to swing joint spare, carries out the insulin injection to the human body through injection subassembly, and test component carries out the blood sugar test to the human body, test component is including having created test group and not having the wound test group, the both ends of test component are do not located to have created test group and not having the wound test group, have created test group and calculate through the size that detects the corresponding electric current of blood and draw accurate blood sugar value, it draws the blood sugar value through infrared spectral analysis to have created test group.
Description
Technical Field
The utility model belongs to the technical field of insulin injection device and blood sugar test equipment, especially, relate to a multi-functional integral type test injection device.
Background
Diabetes is a common, non-infectious, chronic disease that seriously compromises human health, and an important means for delaying diabetes and its complications is to frequently measure the blood glucose concentration of a patient. Diabetic patients traditionally need to monitor their daily blood glucose levels by measuring the blood taken from their fingertips using a conventional testing instrument, which is an uncomfortable pain and high risk of infection, a source of concern.
Most of the instruments for patient feedback, blood sugar test and injection are troublesome to use and operate, and the regular measurement and injection can be realized only at home; when the device is used for playing or working outside, the timing measurement cannot be carried out due to troublesome operation. For the condition of going out, the fact that many patients can not measure regularly often causes serious consequences, leads to the fact that the patient needs to go to hospital in time to treat.
Therefore, there is a need to develop a multifunctional integrated test injection device that is convenient for patients to use.
SUMMERY OF THE UTILITY MODEL
In order to solve the problem that current blood sugar test instrument and injection insulin are not convenient, the utility model provides a multi-functional integral type test injection device.
Compared with the prior art, the utility model innovation part lies in:
the utility model discloses multi-functional integral type test injection device, including swing joint spare, injection subassembly and test assembly, through swing joint spare will inject subassembly and test assembly swing joint as an organic whole, swing joint spare locates the centre of injection subassembly and test assembly, carries out the insulin injection to the human body through the injection subassembly, and test assembly carries out the blood sugar test to the human body.
Furthermore, the test component comprises an invasive test group and a non-invasive test group, the invasive test group and the non-invasive test group are respectively arranged at two ends of the test component, the invasive test group calculates the accurate blood sugar value by detecting the corresponding current of blood, and the non-invasive test group extracts the blood sugar value by the infrared spectrum analysis.
Further, the injection assembly comprises a power tube, a storage tube and a needle head piece, the storage tube is installed below the power tube, the needle head piece is connected with the storage tube, insulin is filled in the storage tube, and the insulin is injected through the power tube and the needle head piece.
Further, it is including microprocessor and rather than infrared emission laser instrument, detector, signal conditioning circuit and the display screen of electricity connection not to have the wound test group, infrared emission laser instrument shines human skin and gives the detector with signal transmission, the detector converts light signal into the signal transmission for signal conditioning circuit and enlargies, filtering, plastic, and microprocessor carries out the correlation operation to human blood glucose concentration and gives the display screen with human blood glucose concentration result transmission.
Furthermore, the invasive test group comprises test paper, an insertion opening and a strip retreating key, the insertion opening is connected with the signal regulating circuit, the microprocessor and the display screen, the strip retreating key is connected with the insertion opening and controls the insertion opening to be tightened or loosened, the test paper is provided with the insertion opening, blood drops on the test paper installed in the insertion opening, and the blood glucose value calculated by the microprocessor is displayed on the display screen.
Further, be equipped with first button and second button on the test assembly, infrared emission laser ware is connected to first button, the inserted hole is connected to the second button, and through the work of first button control noninvasive test group, the work of second button control invasive test group.
Furthermore, the power tube comprises a top, a piston rod and a push key, the top and the push key are respectively arranged at two ends of the piston rod, the piston rod and the top are pushed by pressing the push key, and the top generates pressure in the storage tube.
Further, the storage tube is including the pipe support and locate rubber film, body and the piston in it, the both ends of body are located to rubber film and piston, rubber film is connected with syringe needle spare, the piston is connected with the top of power pipe, the filling has insulin in the body, be equipped with the scale on the pipe support, through observing the volume of scale control injection insulin.
Further, the needle head piece comprises a needle head and a needle cap, wherein threads are arranged in the needle head, the needle head is rotatably connected with the storage tube through the threads, and the needle head is used by uncovering the needle cap.
Furthermore, still be equipped with dose display window on the injection subassembly, dose display window connects and pushes away the key, changes dose display window's numerical value through rotating and pushing away the key, and the numerical value that simultaneously presses and to push away the key and also can change dose display window.
The beneficial effects of the utility model reside in that:
(1) the injection assembly and the test assembly are connected into a whole by the movable connecting piece, and when the portable blood glucose meter is used, the injection assembly and the test assembly are separated by the movable connecting piece to perform respective functions, so that the portable blood glucose meter is convenient and easy to carry, and the problems of untimely blood glucose measurement and insulin injection of a patient due to troublesome use are solved;
(2) the testing component comprises an invasive testing group and a non-invasive testing group, the non-invasive testing group extracts the blood sugar value by combining an infrared emission laser and a detector and through infrared spectrum analysis, the pain feeling and the infection risk are avoided, the invasive testing group obtains the accurate blood sugar value by detecting the corresponding current of blood through blood staining by test paper, and the testing value is more accurate;
(3) the injection assembly is designed in a structure of a pen and a pen, comprises a power tube, a storage tube and a needle head piece, and is light in structure and convenient to use and operate;
(4) and a dose display window and a scale are arranged on the injection assembly, and the dose display window and the scale are used for jointly controlling the amount of the injected insulin.
Drawings
Fig. 1 is a schematic view of the overall structure of the multifunctional integrated test injection device of the present invention;
FIG. 2 is a schematic view of the overall structure of the multifunctional integrated test injection device of the present invention;
FIG. 3 is a schematic structural view of a testing assembly of the multifunctional integrated testing injection device of the present invention;
FIG. 4 is a first exploded view of the injection assembly of the multifunctional integrated test injection apparatus of the present invention with the top thereof not reaching to the bottom;
FIG. 5 is a second exploded view of the injection assembly of the multifunctional integrated test injection device of the present invention;
fig. 6 is a functional block diagram of the testing assembly of the multifunctional integrated testing injection device of the present invention.
In the figure, 1 is a movable connector, 2 is an injection assembly, 21 is a power tube, 211 is a top, 212 is a piston rod, 213 is a push key, 22 is a storage tube, 221 is a tube frame, 2211 is a scale, 222 is a rubber film, 223 is a tube body, 224 is a piston, 23 is a needle head, 231 is a needle head, 212 is a needle cap, 24 is a dose display window, 3 is a test assembly, 31 is a non-invasive test set, 311 is a microprocessor, 312 is an infrared emission laser, 313 is a detector, 314 is a signal regulating circuit, 315 is a display screen, 32 is an invasive test set, 321 is a test paper, 322 is an insertion port, 323 is a strip withdrawing key, 33 is a first key, and 34 is a second key.
Detailed Description
The technical solution in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings of the present invention.
Please refer to fig. 1-6, the utility model provides a multi-functional integral type test injection device, including swing joint spare 1, injection subassembly 2 and test subassembly 3, through swing joint spare 1 is as an organic whole with injection subassembly 2 and test subassembly 3 swing joint, swing joint spare 1 is located injection subassembly 2 and test subassembly 3's centre, carries out insulin injection to the human body through injection subassembly 2, and test subassembly 3 carries out blood sugar test to the human body.
Specifically, the movable connecting piece can be designed into a thread shape, corresponding threads are respectively arranged at the connecting ends of the injection assembly and the test assembly, and the movable connecting piece, the injection assembly and the test assembly are detachably connected through thread rotation; in addition, the movable connecting piece can also be designed into a groove shape, corresponding buckling positions are respectively arranged at the connecting ends of the injection assembly and the test assembly, and the movable connecting piece, the injection assembly and the test assembly can be detachably connected by being clamped in the clamping groove through the buckling positions.
The test component 3 includes an invasive test group 31 and a non-invasive test group 32, the invasive test group 31 and the non-invasive test group 32 are respectively arranged at two ends of the test component 3, the invasive test group 31 calculates an accurate blood sugar value by detecting the magnitude of corresponding current of blood, and the non-invasive test group 32 extracts the blood sugar value by infrared spectrum analysis.
The injection assembly 2 comprises a power tube 21, a storage tube 22 and a needle piece 23, wherein the storage tube 22 is installed below the power tube 21, the needle piece 23 is connected with the storage tube 22, insulin is filled in the storage tube 22, and the insulin is injected through the power tube 21 and the needle piece 23.
Referring to fig. 4, the injection assembly further comprises a tube cover 25, the tube cover 25 is sleeved on the storage tube 22, the storage tube 22 and the needle member 23 are wrapped by the tube cover 25, and one end of the tube cover 25 is provided with a thread or a buckle position to be connected with the movable connecting member 1.
The non-invasive testing group 31 comprises a microprocessor 311, an infrared emission laser 312, a detector 313, a signal regulating circuit 314 and a display screen 315, wherein the infrared emission laser 312 is electrically connected with the microprocessor, the infrared emission laser 312 irradiates the skin of a human body and transmits signals to the detector 313, the detector 313 converts optical signals into electric signals and transmits the electric signals to the signal regulating circuit 314 for amplification, filtering and shaping, and the microprocessor 311 performs correlation operation on the blood glucose concentration of the human body and transmits the blood glucose concentration result of the human body to the display screen. The detector is a TeSnHg photoconductive detector, the sensitive wavelength of the testing component is determined through a spectrum experiment, and the testing component is calculated through spectrum analysis and is weak in capability of penetrating through skin based on mid-infrared light, so that a laser is selected as a light source, a human finger is used as a detection part to construct a mathematical model, and the microprocessor adopts the following models: C8051F 005.
The invasive testing group 32 comprises a test paper 321, an insertion port 322 and a strip returning key 323, wherein the insertion port 322 is connected with the signal regulating circuit 314, the microprocessor 311 and the display screen 315, the strip returning key 323 is connected with the insertion port 322 and controls the insertion port 322 to loosen and tighten the test paper 321, the test paper 321 is arranged at the insertion port 322, blood drops on the test paper 321 arranged at the insertion port 322, and the blood glucose value calculated by the microprocessor 311 is displayed on the display screen 315.
The principle of the invasive test group is as follows: the enzyme electrode test paper is prepared by a screen printing method, about 3 mul of finger blood is collected, glucose in the finger blood and oxidase on the surface of an electrode react quickly to generate oxidation current, and the magnitude of the response current of the blood sample is detected under the control of a single chip microcomputer, so that the accurate blood glucose concentration value is calculated.
The testing component 3 is provided with a first key 33 and a second key 34, the first key 33 is connected with the infrared emission laser 312, the second key 34 is connected with the insertion port 322, the noninvasive testing group 31 is controlled to work through the first key 33, and the invasive testing group 32 is controlled to work through the second key 34.
The power tube 21 comprises a top 211, a piston rod 212 and a push key 213, wherein the top 311 and the push key 313 are respectively arranged at two ends of the piston rod 212, the push key 213 is pressed to push the piston rod 213 and the top 211, and the top 211 generates pressure in the storage tube 22.
The storage tube 22 comprises a tube frame 221, a rubber film 222, a tube body 223 and a piston 224, wherein the rubber film 222, the tube body 223 and the piston 224 are arranged in the tube frame 221, the rubber film 222 and the piston 224 are arranged at two ends of the tube body 223, the rubber film 222 is connected with the needle piece 23, the piston 224 is connected with the top 211 of the power tube 21, insulin is filled in the tube body 223, scales 2211 are arranged on the tube frame 221, and the amount of injected insulin is controlled by observing the scales 2211.
The needle member 23 comprises a needle 231 and a needle cap 232, and the needle 231 is provided with a screw thread (not shown) for screwing the needle 231 to the storage tube and for applying the needle by uncovering the needle cap.
The injection assembly 2 is further provided with a dose display window 24, the dose display window 24 is connected with a push key 213, the numerical value of the dose display window 24 is changed by rotating the push key 213, and the numerical value of the dose display window 24 is also changed by pressing the push key 213.
The method comprises the following steps:
1) pressing the movable connecting piece, rotating or pushing one of the injection assembly and the test assembly, splitting the test assembly and the injection assembly into two parts, selecting a non-invasive test set or an invasive test set, aligning one end of an infrared emission laser to a finger of a human body when the non-invasive test set is used, pressing a first key, waiting for 5 seconds, and displaying a blood glucose concentration value on a window; when the invasive test group is used, firstly, two hands are disinfected, a test paper is taken out from a pot filled with the test paper and inserted into an insertion hole, a finger is pressed by a blood sampling pen to take blood, the tail end of the test paper is contacted with a blood drop, a second key is pressed, and the display window is waited for 5 seconds to show the blood glucose concentration value; when fasting whole blood glucose exceeded 11.1mmol/l (200mg/dl), little or no insulin secretion was indicated. Therefore, when the fasting blood sugar is obviously increased, the diabetes can be diagnosed without other examinations; when 1 hour is fed, the blood sugar is 6.7-9.4 millimoles/liter to be a normal value, the blood sugar exceeding 11.1mmol/L (200mg/dl) is hyperglycemia, which indicates that the insulin secretion is little or lacking, and the blood sugar is less than or equal to 7.8 millimoles/liter to be a normal value after 2 hours;
2) when the hyperglycemia is judged, the patient should inject insulin; opening a cover on the injection assembly, checking the top position of the power tube before installing the storage tube, and manually pushing the top to the bottom of the power tube if the top position is not bottomed, wherein the state shown in FIG. 4 shows that the top is not bottomed, and the top needs to be pushed into the power tube until the top cannot be seen;
3) placing the tube filled with insulin into a tube frame, sterilizing the rubber membrane with alcohol cotton sheet, installing unused needle, and removing the needle cap;
4) then, evacuation is carried out, mainly air in the needle head is discharged, namely the push key is pushed to observe the scale of the tube body, and the piston is pushed to the position which is level to the insulin;
5) the needle head is upwards, the push button is pushed to the bottom, a click is heard, at the moment, a drop of insulin must appear on the needle head, and if the drop of insulin does not appear, the step 4 is required to be returned to carry out emptying action again;
6) pulling the push key, rotating the push key according to the amount of insulin to be injected, enabling the dosage display window to have a corresponding numerical value, inserting the needle into an injection part, pushing the slide button to the bottom, hearing a click sound to indicate that the dosage is completely injected into the subcutaneous tissue, and stopping under the subcutaneous tissue for at least 6 seconds after injection and then pulling out the needle;
7) the needle cap is sleeved on the needle head, and the needle head piece is taken down and thrown into a recycling garbage can, so that the injection is completed;
8) after the test and injection actions are finished, the movable connecting piece is pressed to rotate or push one of the test component and the injection component, and the movable connecting piece, the injection component and the test component are connected into a whole.
The above-mentioned embodiments only represent one embodiment of the present invention, and the description thereof is specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for those skilled in the art, without departing from the spirit of the present invention, several variations and modifications can be made, which are within the scope of the present invention. Therefore, the protection scope of the present invention should be subject to the appended claims.
Claims (8)
1. The multifunctional integrated test injection device is characterized by comprising a movable connecting piece, an injection assembly and a test assembly, the injection component and the testing component are movably connected into a whole through the movable connecting piece, the movable connecting piece is arranged between the injection component and the testing component, the testing component comprises an invasive testing group and a non-invasive testing group, the invasive testing group and the non-invasive testing group are respectively arranged at two ends of the testing component, the invasive test group calculates the accurate blood sugar value by detecting the corresponding current of the blood, the noninvasive test group extracts the blood sugar value through the infrared spectral analysis, the injection component comprises a power tube, a storage tube and a needle head piece, the storage tube is installed in power tube below, the storage tube is connected to the syringe needle spare, the filling has insulin in the storage tube, injects insulin through power tube and syringe needle spare.
2. The multifunctional integrated testing and injecting device as claimed in claim 1, wherein the non-invasive testing set comprises a microprocessor, an infrared emitting laser, a detector, a signal conditioning circuit and a display screen, the infrared emitting laser, the detector, the signal conditioning circuit and the display screen are electrically connected with the microprocessor, the infrared emitting laser irradiates the skin of the human body and transmits signals to the detector, the detector converts optical signals into electrical signals and transmits the electrical signals to the signal conditioning circuit for amplification, filtering and shaping, and the microprocessor performs correlation operation on the blood glucose concentration of the human body and transmits the result of the blood glucose concentration of the human body to the display screen.
3. The multifunctional integrated test injection device according to claim 2, wherein the invasive test group comprises a test paper, an insertion port and a strip withdrawing key, the insertion port is connected with the signal conditioning circuit, the microprocessor and the display screen, the strip withdrawing key is connected with the insertion port and controls the tightness of the test paper of the insertion port, the test paper is provided with the insertion port, and the blood glucose value calculated by the microprocessor is displayed on the display screen by dropping blood on the test paper installed at the insertion port.
4. The multifunctional integrated test injection device according to claim 3, wherein the test assembly is provided with a first button and a second button, the first button is connected with the infrared emission laser, the second button is connected with the insertion port, the first button is used for controlling the operation of the non-invasive test group, and the second button is used for controlling the operation of the invasive test group.
5. The multifunctional integrated testing and injecting device as claimed in claim 1, wherein the power tube comprises a top portion, a piston rod and a push key, the top portion and the push key are respectively disposed at two ends of the piston rod, the piston rod and the top portion are pushed by pressing the push key, and the top portion generates pressure in the storage tube.
6. The multifunctional integrated testing and injecting device as claimed in claim 1, wherein the storage tube comprises a tube frame, and a rubber membrane, a tube body and a piston arranged in the tube frame, the rubber membrane and the piston are arranged at two ends of the tube body, the rubber membrane is connected with the needle head piece, the piston is connected with the top of the power tube, insulin is filled in the tube body, the tube frame is provided with scales, and the amount of injected insulin is controlled by observing the scales.
7. The multifunctional integrated test injection device according to claim 1, wherein the needle member comprises a needle and a needle cap, the needle is internally provided with a thread, the needle is rotatably connected with the storage tube through the thread, and the needle is used by uncovering the needle cap.
8. The multifunctional integrated test injection device according to claim 1, wherein the injection assembly is further provided with a dosage display window, the dosage display window is connected with a push key, and the numerical value of the dosage display window is changed by rotating the push key.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202020840275.7U CN213374413U (en) | 2020-05-19 | 2020-05-19 | Multifunctional integrated test injection device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202020840275.7U CN213374413U (en) | 2020-05-19 | 2020-05-19 | Multifunctional integrated test injection device |
Publications (1)
Publication Number | Publication Date |
---|---|
CN213374413U true CN213374413U (en) | 2021-06-08 |
Family
ID=76177664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202020840275.7U Active CN213374413U (en) | 2020-05-19 | 2020-05-19 | Multifunctional integrated test injection device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN213374413U (en) |
-
2020
- 2020-05-19 CN CN202020840275.7U patent/CN213374413U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9456782B2 (en) | Systems for withdrawing body fluid and methods for configuring systems for withdrawing body fluids | |
RU2343833C2 (en) | Integral sample gauge | |
EP2061375B1 (en) | Body fluid monitoring and sampling devices | |
US20080200838A1 (en) | Wearable, programmable automated blood testing system | |
US20040267229A1 (en) | In-situ adapter for a testing device | |
CN103040475B (en) | Glucose tolerance analyzer, glucose tolerance analyzing system, and storage medium | |
AU2004236681B2 (en) | Zero corrected optical blood analyte detector | |
CN213374413U (en) | Multifunctional integrated test injection device | |
CN212394897U (en) | Device for detecting sensitivity of human body local to pressure-induced pain | |
JPH1028683A (en) | Blood sugar value meter integrally incorporated with lancet | |
CN213374414U (en) | Integrated test injection device | |
WO2021128154A1 (en) | Peripheral blood collection device | |
CN208355457U (en) | A kind of common examination instrument | |
CN205003163U (en) | Portable quick blood sugar tests appearance | |
CN104622449A (en) | Diabetes treatment case | |
CN211187273U (en) | Artery puncture needle device for measuring blood oxygen saturation and blood pressure | |
CN104983423B (en) | Multifunctional health detector | |
CN208404596U (en) | A kind of portable diabetes glucose measuring device | |
CN215424635U (en) | Combined noninvasive blood glucose detector based on metabolic heat method | |
CN216318020U (en) | Portable blood glucose meter for internal medicine clinic | |
CN110786836A (en) | Multi-channel noninvasive physiological and biochemical parameter measuring device with user operation interface | |
CN117017279A (en) | Multi-parameter fusion noninvasive glucometer | |
KR20210043775A (en) | Non-invasive system for testing blood sugar and method of the same | |
CN104473651A (en) | Infrared spectrum technology non-invasive blood glucose instrument |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |